Meta-analysis of the risks of arterial and venous occlusive events with new generation BCR-ABL TKIs in patients with chronic myeloid leukaemia

Résultats de recherche: Contribution à un événement scientifique (non publié)Poster

langue originaleAnglais
étatPublié - 10 juin 2016
Evénement21st congress of the European Hematology Association - Copenhague, Danemark
Durée: 9 juin 201612 juin 2016

Colloque

Colloque21st congress of the European Hematology Association
Titre abrégé21st congress of EHA
PaysDanemark
La villeCopenhague
période9/06/1612/06/16

Citer ceci

@conference{5485a8c4d7d64925ad277e40dbe531ee,
title = "Meta-analysis of the risks of arterial and venous occlusive events with new generation BCR-ABL TKIs in patients with chronic myeloid leukaemia",
keywords = "arterial thrombosis, chronic myeloid leukemia, tyrosine kinase inhibator, venous thromboembolism",
author = "H{\'e}l{\`e}ne Haguet and Jonathan Douxfils and Fran{\cc}ois Mullier and Carlos Graux and Christian Chatelain and Jean-Michel Dogne",
year = "2016",
month = "6",
day = "10",
language = "English",
note = "21st congress of the European Hematology Association, 21st congress of EHA ; Conference date: 09-06-2016 Through 12-06-2016",

}

Meta-analysis of the risks of arterial and venous occlusive events with new generation BCR-ABL TKIs in patients with chronic myeloid leukaemia. / Haguet, Hélène; Douxfils, Jonathan; Mullier, François; Graux, Carlos; Chatelain, Christian; Dogne, Jean-Michel.

2016. Poster présenté � 21st congress of the European Hematology Association, Copenhague, Danemark.

Résultats de recherche: Contribution à un événement scientifique (non publié)Poster

TY - CONF

T1 - Meta-analysis of the risks of arterial and venous occlusive events with new generation BCR-ABL TKIs in patients with chronic myeloid leukaemia

AU - Haguet, Hélène

AU - Douxfils, Jonathan

AU - Mullier, François

AU - Graux, Carlos

AU - Chatelain, Christian

AU - Dogne, Jean-Michel

PY - 2016/6/10

Y1 - 2016/6/10

KW - arterial thrombosis

KW - chronic myeloid leukemia

KW - tyrosine kinase inhibator

KW - venous thromboembolism

M3 - Poster

ER -